Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002229830 | SCV000944809 | uncertain significance | Familial focal epilepsy with variable foci | 2024-07-01 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 1162 of the DEPDC5 protein (p.Ser1162Gly). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Rolandic epilepsy (PMID: 24591017, 29358611). This variant is also known as c.3457A>G, p.S1153G, and g.32266729A>G. ClinVar contains an entry for this variant (Variation ID: 264762). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Not Available"; Align-GVGD: "Not Available". The glycine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies have shown that this missense change does not substantially affect DEPDC5 function (PMID: 25366275). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000254595 | SCV000321060 | not provided | Epilepsy, familial focal, with variable foci 1 | no assertion provided | literature only | ||
Bioinformatics Core, |
RCV000656076 | SCV000588352 | pathogenic | Self-limited epilepsy with centrotemporal spikes | 2017-01-01 | no assertion criteria provided | case-control | CAADphred>15 |